Sonoma Pharmaceuticals, Inc.
SNOA
$2.79
$0.8040.20%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -7.16% | 58.89% | 19.39% | 18.43% | 55.34% |
| Total Depreciation and Amortization | -26.67% | -22.22% | -13.33% | 20.59% | 40.63% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -106.82% | -76.19% | -17.92% | -93.95% | -35.77% |
| Change in Net Operating Assets | 495.15% | 777.67% | -111.33% | 169.81% | -126.09% |
| Cash from Operations | 151.18% | 128.76% | -324.19% | 106.23% | -217.24% |
| Capital Expenditure | -100.00% | -1,200.00% | 70.59% | 101.58% | 96.77% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -86.11% | -- |
| Cash from Investing | -100.00% | -1,200.00% | 70.59% | 121.95% | -102.94% |
| Total Debt Issued | -- | -- | -- | -27.57% | -- |
| Total Debt Repaid | 35.94% | 5.43% | 8.46% | 6.00% | 40.19% |
| Issuance of Common Stock | -45.18% | -- | -- | -88.21% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -94.38% | 105.62% |
| Cash from Financing | -46.28% | 1,219.38% | 571.11% | -81.55% | 514.47% |
| Foreign Exchange rate Adjustments | -301.79% | -528.89% | -383.52% | -120.77% | 165.88% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 330.48% | 205.83% | -95.29% | -39.12% | 137.52% |
